Dystrophin: from non-ischemic cardiomyopathy to ischemic cardiomyopathy

Qiang Sun Zheng1, Wan Gang Guo, Zi Fan Lu

  • 1Department of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China. tdxnsys@fmmu.edu.cn

Medical Hypotheses
|June 20, 2008
PubMed

Insights

Dystrophin protein is crucial for heart muscle health, protecting against genetic and viral cardiomyopathies. Restoring dystrophin may offer new treatments for ischemic cardiomyopathy by aiding ventricular remodeling.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Genetics

Background:

  • Dystrophin and associated proteins form a vital scaffold connecting the cardiomyocyte cytoskeleton to the extracellular matrix.
  • Mutations in dystrophin, located on the X chromosome, are linked to Duchenne muscular dystrophy, Becker muscular dystrophy, and X-linked dilated cardiomyopathy.

Purpose of the Study:

  • To review the structure, distribution, and role of dystrophin in genetic and viral dilated cardiomyopathies.
  • To hypothesize dystrophin's critical role in ventricular remodeling in ischemic myocardium.

Main Methods:

  • Literature review focusing on dystrophin structure and function.
  • Analysis of research on dystrophin's involvement in various forms of cardiomyopathy.
  • Exploration of potential therapeutic strategies targeting dystrophin.

Main Results:

  • Dystrophin disruption is implicated in both genetic (e.g., X-linked dilated cardiomyopathy) and acquired (e.g., viral) forms of dilated cardiomyopathy.
  • The review synthesizes current knowledge on dystrophin's function in cardiomyocyte integrity.

Conclusions:

  • Dystrophin is essential for maintaining cardiomyocyte membrane stability and preventing cardiomyopathies.
  • Targeting dystrophin restoration may represent a novel therapeutic approach for ischemic cardiomyopathy and ventricular remodeling.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...